Abstract Background Interventional therapies (ITs) are an emerging treatment modality for
pulmonary embolism (PE); however, the degree of racial, sex-based, and sociodemographic …

Acute pulmonary embolism (PE) remains a significant cause of morbidity and requires
prompt diagnosis and management. The prognosis of affected patients depends on the …

Pulmonary embolism (PE) is a significant cause of cardiovascular mortality, with varying
presentations and management challenges. Traditional treatment approaches often differ …

Diagnostic and therapeutic decision-making in pregnancy with suspected pulmonary
embolism (PE) is challenging. European and other international professional societies have …

Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with
no breakthrough therapies shown to improve survival over the past few decades. It is a time …

Abstract Purpose of Review Acute pulmonary embolism (PE) is a leading cause of
cardiovascular death and morbidity, and presents a major burden to healthcare systems …

Pulmonary embolism (PE) remains both difficult to diagnose and complex to treat despite
over 50 years of recognition as a cause of significant morbidity and mortality. 1 Behind …

Background Pulmonary embolism (PE) is a major cause of mortality with presentation
varying between few or no symptoms to sudden death. This makes timely and appropriate …

High-risk pulmonary embolism (PE) refers to a large embolic burden causing right
ventricular failure and hemodynamic instability. It accounts for approximately 5% of all cases …

Background: Systemic thrombolysis (ST) is the guideline-recommended treatment for high-
risk pulmonary embolism (PE), although catheter-directed thrombolysis (CDT) may provide a …